Operating Expenses. 9.1. As used herein, the term “Operating Expenses” shall include:
Appears in 45 contracts
Sources: Lease (Fractyl Health, Inc.), Lease (Erasca, Inc.), Lease (Monte Rosa Therapeutics, Inc.)
Operating Expenses. 9.1. 9.1 As used herein, the term “Operating Expenses” shall include:
Appears in 12 contracts
Sources: Lease Agreement (Turnstone Biologics Corp.), Lease (Pyxis Oncology, Inc.), Lease (Cue Health Inc.)
Operating Expenses. 9.17.1. As used herein, the term “Operating Expenses” shall include:
Appears in 12 contracts
Sources: Sublease Agreement (Atara Biotherapeutics, Inc.), Lease (CareDx, Inc.), Lease (CareDx, Inc.)
Operating Expenses. 9.1. 7.1 As used herein, the term “"Operating Expenses” " shall include:
Appears in 7 contracts
Sources: Lease (Nastech Pharmaceutical Co Inc), Lease Agreement (Epoch Biosciences Inc), Lease (Cytel Corp/De)
Operating Expenses. 9.110.1. As used herein, the term “Operating Expenses” shall include:
Appears in 5 contracts
Sources: Lease (Ardelyx, Inc.), Lease (Ardelyx, Inc.), Lease (Revance Therapeutics, Inc.)
Operating Expenses. 9.1. 7.1 As used herein, the term “Operating Expenses” shall include:
Appears in 5 contracts
Sources: Lease (Genelux Corp), Lease (Genelux Corp), Lease (Acucela Inc)
Operating Expenses. 9.1. 8.1 As used herein, the term “Operating Expenses” shall include:
Appears in 3 contracts
Sources: Lease (NanoString Technologies Inc), Lease (NanoString Technologies Inc), Lease (NanoString Technologies Inc)
Operating Expenses. 9.1. 10.1 As used herein, the term “Operating Expenses” shall include:
Appears in 3 contracts
Sources: Lease (Tocagen Inc), Lease (Tocagen Inc), Lease (Tocagen Inc)
Operating Expenses. 9.1. As used herein, the The term “"Operating Expenses” " shall includemean:
Appears in 2 contracts
Sources: Modification Agreement (Stratus Properties Inc), Fourth Modification Agreement (Stratus Properties Inc)
Operating Expenses. 9.18.1. As used herein, the term “Operating Expenses” shall include:
Appears in 2 contracts
Sources: Lease (Halozyme Therapeutics Inc), Lease (Halozyme Therapeutics Inc)
Operating Expenses. 9.17.1. As used herein, the term “"Operating Expenses” " shall include:
Appears in 2 contracts
Sources: Lease Agreement (Antex Biologics Inc), Lease Agreement (Matrix Pharmaceutical Inc/De)
Operating Expenses. 9.1. As used herein, the term “Operating Expenses” shall include:
Appears in 1 contract
Sources: Lease Agreement (Codex DNA, Inc.)
Operating Expenses. 9.1. As used herein, the 10.1 The term “Operating Expenses” shall include:
Appears in 1 contract
Sources: Lease (Revance Therapeutics, Inc.)
Operating Expenses. 9.1. As used herein, the term “Operating Expenses” shall include:include (subject to the exclusions set forth in Section 9.1(c)):
Appears in 1 contract
Sources: Lease (REGENXBIO Inc.)